全文获取类型
收费全文 | 946篇 |
免费 | 49篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 26篇 |
妇产科学 | 10篇 |
基础医学 | 202篇 |
口腔科学 | 18篇 |
临床医学 | 84篇 |
内科学 | 186篇 |
皮肤病学 | 64篇 |
神经病学 | 60篇 |
特种医学 | 29篇 |
外科学 | 79篇 |
综合类 | 3篇 |
预防医学 | 123篇 |
眼科学 | 14篇 |
药学 | 23篇 |
肿瘤学 | 72篇 |
出版年
2023年 | 4篇 |
2020年 | 7篇 |
2019年 | 8篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 13篇 |
2015年 | 16篇 |
2014年 | 27篇 |
2013年 | 37篇 |
2012年 | 49篇 |
2011年 | 40篇 |
2010年 | 28篇 |
2009年 | 23篇 |
2008年 | 52篇 |
2007年 | 61篇 |
2006年 | 63篇 |
2005年 | 45篇 |
2004年 | 58篇 |
2003年 | 41篇 |
2002年 | 56篇 |
2001年 | 18篇 |
2000年 | 20篇 |
1999年 | 23篇 |
1998年 | 16篇 |
1997年 | 20篇 |
1996年 | 13篇 |
1995年 | 7篇 |
1994年 | 12篇 |
1993年 | 10篇 |
1992年 | 19篇 |
1991年 | 9篇 |
1990年 | 14篇 |
1989年 | 17篇 |
1988年 | 12篇 |
1987年 | 7篇 |
1986年 | 6篇 |
1985年 | 11篇 |
1984年 | 8篇 |
1983年 | 10篇 |
1982年 | 11篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1979年 | 6篇 |
1978年 | 7篇 |
1977年 | 4篇 |
1976年 | 9篇 |
1975年 | 6篇 |
1973年 | 4篇 |
1972年 | 5篇 |
1967年 | 3篇 |
排序方式: 共有997条查询结果,搜索用时 15 毫秒
1.
2.
3.
Inter-cohort differences in coronary heart disease mortality in the 25-year follow-up of the seven countries study 总被引:2,自引:0,他引:2
A. Menotti A. Keys D. Kromhout H. Blackburn C. Aravanis B. Bloemberg R. Buzina A. Dontas F. Fidanza S. Giampaoli M. Karvonen M. Lanti I. Mohacek S. Nedeljkovic A. Nissinen J. Pekkanen S. Punsar F. Seccareccia H. Toshima 《European journal of epidemiology》1993,9(5):527-536
Sixteen cohorts of men aged 40–59 years at entry were examined with the measurement of some risk factors and then followed-up for mortality and causes of death for 25 years. These cohorts were located in the USA (1 cohort), Finland (2), the Netherlands (1), Italy (3), the former Yugoslavia (5), Greece (2), and Japan (2), and included a total of 12,763 subjects.Large differences in age-adjusted coronary heart disease (CHD) death rates were found, with extremes of 45 per 1000 in 25 years in Tanushimaru, Japan, to 288 per 1000 in 25 years in East Finland. In general, higher rates were found in the US and Northern European cohorts as compared to the Southern European and Japanese cohorts. However, during the last 10 years of follow-up large increases of CHD death rates were found in some Yugoslavian areas. Out of 5 measured entry characteristics treated as age-adjusted levels (serum cholesterol, systolic blood pressure, cigarette smoking, body mass index and physical activity at work), only serum cholesterol was significant in explaining cohort differences in CHD death rates.Over 50% of the variance in CHD death rates in 25 years was accounted for by the difference in mean serum cholesterol. This association tended to decline with increasing length of follow-up, but this was due to the great changes in mean serum cholesterol in the two Jugoslavian cohorts of Velika Krsna and Zrenjanin. When these two cohorts were excluded the association increased with time.Changes in mean serum cholesterol between year 0 and 10 helped in explaining differences in CHD death rates from year 10 onward.It can be concluded that this study suggests that mean serum cholesterol is the major risk factor in explaining cross-cultural differences in CHD. 相似文献
4.
Mohamed Guled Samuel Myllykangas Henry F Frierson Stacey E Mills Sakari Knuutila Edward B Stelow 《Modern pathology》2008,21(6):770-778
Olfactory neuroblastoma is an unusual neuroectodermal malignancy, which is thought to arise at the olfactory membrane of the sinonasal tract. Due to its rarity, little is understood regarding its molecular and cytogenetic abnormalities. The aim of the current study is to identify specific DNA copy number changes in olfactory neuroblastoma. Thirteen dissected tissue samples were analyzed using array comparative genomic hybridization. Our results show that gene copy number profiles of olfactory neuroblastoma samples are complex. The most frequent changes included gains at 7q11.22-q21.11, 9p13.3, 13q, 20p/q, and Xp/q, and losses at 2q31.1, 2q33.3, 2q37.1, 6q16.3, 6q21.33, 6q22.1, 22q11.23, 22q12.1, and Xp/q. Gains were more frequent than losses, and high-stage tumors showed more alterations than low-stage olfactory neuroblastoma. Frequent changes in high-stage tumors were gains at 13q14.2-q14.3, 13q31.1, and 20q11.21-q11.23, and loss of Xp21.1 (in 66% of cases). Gains at 5q35, 13q, and 20q, and losses at 2q31.1, 2q33.3, and 6q16-q22, were present in 50% of cases. The identified regions of gene copy number change have been implicated in a variety of tumors, especially carcinomas. In addition, our results indicate that gains in 20q and 13q may be important in the progression of this cancer, and that these regions possibly harbor genes with functional relevance in olfactory neuroblastoma. 相似文献
5.
6.
7.
The failure to identify biomarkers of clinical significance for cancer diagnosis and prognosis generated a great deal of skepticism in regard to the usefulness of autoantibody-based methods. SEREX was a major advancement in immunoscreening that resulted in the identification of a large group of autoantigens recognized by cancer sera. However, few SEREX-defined autoantigens have proven to have definitive diagnostic value in clinical practice. Often, the identified antigens are patient-specific rather than tumor-specific and many tumor-associated antigens are rare in expression libraries made from non-autologous cells. Since autoantibodies are part of the normal immune response, it can be difficult to single out tumor-associated antibodies from the scores of irrelevant patient-specific responses. In our view, any practical approach for identifying cancer-related autoantigens must include an integral strategy for demonstrating tumor relevance early in the screening process. Care must also be taken not to exclude potentially important autoantibodies by pre-screening manipulations to patient sera. We have introduced substantial modifications in SEREX, designed to minimize confounding effects of unrelated autoantibodies and to eliminate steps that preclude the identification of cancer-related autoantigens commonly recognized by cancer sera. In addition, we incorporate methodology to identify candidate antigens that have potential diagnostic or prognostic value prior to their molecular cloning and characterization. 相似文献
8.
9.
10.
Virpi Rantanen Seija Grénman Kaisa Kurvinen Sakari Hietanen Misa Raitanen Stina Syrjänen 《Gynecologic oncology》1998,71(3):352-358
Objective.The correlation betweenp53tumor suppressor gene mutations and the presence of high-risk human papillomavirus (HPV) DNA with thein vitroradiosensitivity of gynecological malignancies was studied in 26 cell lines derived from gynecological cancers of 23 patients.Methods.Comparison of the intrinsic radiosensitivity was performed with mean inactivation dose (D?) determined with the 96-well plate clonogenic assay.p53mutations were investigated with polymerase chain reaction and single-strand conformation polymorphism (PCR–SSCP) analysis and direct DNA sequencing, and the presence of HPV DNA was studied with PCR using HPV consensus primers.Results. p53mutations were found in 6 of 10 vulvar squamous cell carcinoma (SCC) lines. Nine vulvar and 1 vaginal SCC cell lines were HPV DNA negative and 1 vulvar cell line was HPV 16 positive. All 4 cervical SCC lines were HPV positive and possessed the wild-typep53.Three cell lines expressed HPV 16 and 1 HPV 68. Among 10 endometrial cancer cell lines, 2 cell lines with mutantp53and 1 HPV 16 positive cell line were found. No correlation could be demonstrated between inactivation of thep53gene and radiosensitivityin vitro;the cell lines were evaluated as one group or according to their anatomical origin or histology.Conclusion.Our results indicate that inactivation of thep53gene through mutation or binding with HPV DNA does not increase the resistance of gynecological malignancies to ionizing radiationin vitro. 相似文献